Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

BMS starts phase I study of psoriasis candidate BMS-986165

Nov. 13, 2015

LEO Pharma to acquire global dermatology portfolio from Astellas Pharma

Nov. 12, 2015

Biosimilar etanercept achieves endpoints in phase III psoriasis study

Nov. 10, 2015

InMed provides update on development program for epidermolysis bullosa

Nov. 9, 2015

Calcipotriol formulation has promising effects in patients with nail psoriasis

Nov. 6, 2015

Osiris Therapeutics confirms addition to its wound care portfolio

Nov. 6, 2015

Phase II study of AQX-1125 in atopic dermatitis does not meet primary endpoint

Nov. 5, 2015

OliX Pharmaceuticals discloses its cell-penetrating asymmetric siRNA technology

Nov. 5, 2015

Shionogi licenses decubitus ulcer candidate SR-0379 from FunPep

Oct. 30, 2015

LEO-43204 is effective for treating actinic keratosis on the face and chest

Oct. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.